Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
Clinical trial NCT03769194 · COMPLETED
Trial details
- NCT number
- NCT03769194
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2019-12-18
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.